Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The authors reply

Roberts, Darren M. PhD, FRACP; Hoffman, Robert S. MD; Gosselin, Sophie MD; Megarbane, Bruno MD; Yates, Christopher MD; Ghannoum, Marc MD

doi: 10.1097/CCM.0000000000001006
Online Letters to the Editor

Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland, Brisbane, QLD, Australia, and Drug Health Clinical Services, Royal Prince Alfred Hospital, Sydney, NSW, Australia

Division of Medical Toxicology, Department of Emergency Medicine, New York University School of Medicine, New York, NY

Department of Emergency Medicine, Medical Toxicology Service, McGill University Health Centre, McGill University, Montréal, QC, Canada

Réanimation Médicale et Toxicologique, Hôpital Lariboisière, INSERM U1144, Université Paris-Diderot, Paris, France

Emergency Medicine Department/Clinical Toxicology Unit, Hospital Universitari Son Espases, Palma de Mallorca, Spain

Department of Medicine, University of Montreal, Verdun Hospital, Montreal, QC, Canada

Dr. Roberts received support for travel from Amgen (paid into a public hospital departmental trust fund, which was subsequently allocated to Dr. Roberts as a contribution to costs to attend a scientific meeting in US in 2010. At this meeting, a short preliminary meeting by EXTRIP was held during the larger meeting) and from the Research Institute from Verdun Hospital, Montreal, QC, Canada (Dr. Roberts was recently informed that this group provided funds to support attendance at a face-to-face meeting for EXTRIP). He also received support for travel in 2011 as the recipient of a Fellowship from the Royal Australasian College of Physicians, ANZSN, University of Cambridge, and Amgen (Australia) (this was to support work in Cambridge in renal medicine and was otherwise unrestricted). Dr. Gosselin served as a board member for the American Academy of Clinical Toxicology Board of Trustee (unpaid position), is employed by the Government of Quebec Health Ministry, lectured for the Canadian Association of Emergency Physicians and the Association des Médecins d’Urgence du Québec (Honorarium for CME course speaker), and received support for the development of educational presentations from the Canadian Association of Emergency Physicians-Tox Roadshow CME. Dr. Yates received support for travel from the Research Institute from Verdun Hospital Montreal QC, Canada, is employed by Hospital Son Espases (Primary Employment as Emergency Room Physician), lectured for EBAP (Balear School of Public Administration) and the European Commision through TAIEX, and received support for travel from the European Commission and Croatian Agency for combating drug abuse. Dr. Yates and his institution received grant support from the European Commission (Euro-DEM JUST/2012/DPIP/AG/3591 Payment for work on design and exploitation of research on emergencies related to acute drug toxicity, establishing sentinel network). The remaining authors have disclosed that they do not have any potential conflicts of interest.

Copyright © by 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.